Overview

Memantine and Validation of a New Alzheimer's Disease Scale

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
To validate a new Alzheimer's Disease scale against other rating tools in subjects with dementia of Alzheimer's type, treated with memantine.
Phase:
Phase 3
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
Memantine